Curosurf 120Mg/1.5Ml Inj belongs to a class of drugs called pulmonary surfactants. It is used to treat premature infants suffering from or at risk of a condition called respiratory distress syndrome (RDS). Respiratory distress syndrome, or RDS, is caused by insufficient surfactant in the lungs.
Curosurf 120Mg/1.5Ml Inj contains Poractant Alfa, a natural surfactant that works in the same way as human surfactant. It will help your baby breathe normally until it produces its own surfactant.
Curosurf 120Mg/1.5Ml Inj will be given to your baby in a hospital by a suitably trained doctor. In some cases, Curosurf 120Mg/1.5Ml Inj may cause a slow heart rate, low blood pressure, endotracheal tube blockage, and low blood oxygen levels.
The administration of Curosurf 120Mg/1.5Ml Inj to your newborn may impair your baby's lungs' ability to absorb oxygen. As a result, your baby will be closely monitored by a nurse or doctor so that oxygen and ventilatory support can be adjusted as needed. If your baby has any problems while being treated with Curosurf 120Mg/1.5Ml Inj, consult your doctor as soon as possible, even if you do not know the condition is related to the medicine.